Clinical Trials Browser

INDUSTRY × anlotinib × Tumor-Agnostic × Clear all

NCT01878448 2019-05-22

ALTN/STS

Phase 2 Completed

Neoplasms

NCT01874873 2019-05-21

ALTN/MTC

Phase 2 Completed

Neoplasms

NCT02752516 2017-09-18

A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics

Phase 1 Unknown

Neoplasms